Market Place
Sourcing Support
Simulations Plus Unveils Q2 Fiscal 2026 Financial Result
09 Apr 2026 //
PHARMIWEB
Simulations Plus Sets Q2 FY26 Earnings Call Date
26 Mar 2026 //
BUSINESSWIRE
Simulations Plus Launches AI-Enabled Modeling Collaboration
26 Mar 2026 //
PHARMIWEB
Simulations Plus Hosts Summit On Responsible AI In MIDD
03 Mar 2026 //
BUSINESSWIRE
Simulations Plus To Participate In Upcoming Investor Conferences
03 Feb 2026 //
BUSINESSWIRE
Simulations Plus Unveils Q1 Fiscal 2026 Financials
08 Jan 2026 //
BUSINESSWIRE
Simulations Plus` Investor Day on Model-Informed Drug Development
18 Dec 2025 //
PHARMIWEB
Simulations Plus Reveals Q1 Fy2026 Earnings & Conference Call
17 Dec 2025 //
BUSINESSWIRE
Simulations Plus Unveils Q4 And Fy2025 Financial Results
01 Dec 2025 //
BUSINESSWIRE
Simulations Plus Reveals Fy2025 Results, FY2026 Guidance
22 Oct 2025 //
BUSINESSWIRE
Simulations Plus to Participate in Upcoming Investor Conferences
27 Aug 2025 //
BUSINESSWIRE
Simulations Plus Reports Q3 Fiscal 2025 Results
14 Jul 2025 //
BUSINESSWIRE
Simulations Plus Invests in Tech Firm Nurocor
14 Jul 2025 //
BUSINESSWIRE
Simulations Plus Reschedules Q3 2025 Earnings Call
18 Jun 2025 //
BUSINESSWIRE
Simulations Plus to Join Citizens Medical Devices Forum
12 Jun 2025 //
BUSINESSWIRE
Simulations Plus Preliminary Q3 Fiscal 2025 Revenue
11 Jun 2025 //
BUSINESSWIRE
Simulations Plus Releases ADMET Predictor® 13
05 Jun 2025 //
BUSINESSWIRE
Simulations Plus Releases DILIsym® 11
15 May 2025 //
BUSINESSWIRE
Simulations Plus Reports Q2 Fiscal 2025 Results
03 Apr 2025 //
BUSINESSWIRE
Simulations Plus Announces Q2 FY2025 Earnings and Call Date
20 Mar 2025 //
BUSINESSWIRE
Simulations Plus To Present At KeyBanc Healthcare Investor Forum
10 Mar 2025 //
BUSINESSWIRE
Simulations Plus to Participate in Healthcare Investor Conferences
04 Feb 2025 //
BUSINESSWIRE
Simulations Plus Collaborates to Advance GastroPlus Enhancements
22 Jan 2025 //
BUSINESSWIRE
Simulations Plus Aided FDA-Approved Drugs Development in 2024
13 Jan 2025 //
BUSINESSWIRE
Simulations Plus Reports Q1 Fiscal 2025 Financial Results
07 Jan 2025 //
BUSINESSWIRE
Simulations Plus Announces Q1 FY 2025 Earnings & Call Date
17 Dec 2024 //
BUSINESSWIRE
Simulations Plus & UConn Receive FDA Grant for Injectable Modeling
13 Nov 2024 //
BUSINESSWIRE
Simulations Plus to Join Stephens Annual Investment Conference
06 Nov 2024 //
BUSINESSWIRE
Simulations & Partners Award FDA Grant for Extrapolation Methods
30 Oct 2024 //
BUSINESSWIRE
Simulations Plus Reports Q4 and Fiscal 2024 Financial Results
23 Oct 2024 //
BUSINESSWIRE
Simulations Plus Announces Q4 And FY2024 Earnings Call Date
09 Oct 2024 //
BUSINESSWIRE
Simulations Plus To Attend Morgan Stanley Healthcare Conference
28 Aug 2024 //
BUSINESSWIRE
Simulations Plus Optimizes Business Structure After Strategic Acquisitions
23 Aug 2024 //
BUSINESSWIRE
Simulations Plus Releases ADMET Predictor® Version 12
30 Jul 2024 //
BUSINESSWIRE
Simulations Plus To Join KeyBanc Technology Leadership Forum
25 Jul 2024 //
BUSINESSWIRE
Simulations Plus Announces New Cosmetics Safety Research Project
11 Jul 2024 //
BUSINESSWIRE
Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results
02 Jul 2024 //
BUSINESSWIRE
Simulations Plus To Attend Morgan Stanley Life Sciences AI Summit
20 Jun 2024 //
BUSINESSWIRE
Simulations Plus Announces Q3 FY 2024 Earnings And Conference Call Date
18 Jun 2024 //
BUSINESSWIRE
Simulations Plus Acquires Pro-Ficiency For Drug Development Platform
12 Jun 2024 //
BUSINESSWIRE
Simulations Plus Releases GastroPlus X PBPK Modeling Software
15 May 2024 //
BUSINESSWIRE
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
04 Apr 2024 //
BUSINESSWIRE
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
03 Apr 2024 //
BUSINESSWIRE
Simulations Plus Announces Second Quarter 2024 Earnings and Conference Call Date
20 Mar 2024 //
BUSINESSWIRE
Simulations Plus to Present at KeyBanc Capital Markets Virtual Investor Forum
13 Mar 2024 //
BUSINESSWIRE
Simulations Plus and the University of Bath Awarded New FDA Grant
05 Mar 2024 //
BUSINESSWIRE
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
15 Feb 2024 //
BUSINESSWIRE
Simulations Plus Launches Corporate Development Initiative
13 Feb 2024 //
BUSINESSWIRE
Simulations Plus to Participate in Upcoming Healthcare Conferences
06 Feb 2024 //
BUSINESSWIRE
Simulations Plus Embarks on Collaboration with Northeastern University
09 Jan 2024 //
BUSINESSWIRE
Simulations Plus Announces Leadership Appointments
03 Jan 2024 //
BUSINESSWIRE
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results
03 Jan 2024 //
BUSINESSWIRE
Simulations Plus Announces Q1 Fiscal Year 2024 Earnings and Conference
20 Dec 2023 //
BUSINESSWIRE
Simulations Plus Outlines Paths to Win at 2023 Investor Day
14 Nov 2023 //
BUSINESSWIRE
Simulations Plus to Host Investor Day on Tuesday, November 14th
31 Oct 2023 //
BUSINESSWIRE
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
25 Oct 2023 //
BUSINESSWIRE
Simulations Plus Receives New FDA Grant Award
21 Sep 2023 //
BUSINESSWIRE
Simulations Plus Hosts Summer Camp for Students and Professors
07 Sep 2023 //
BUSINESSWIRE
Simulations Plus CSO Dr. Viera Lukacova Honored as Fellow by AAPS
24 Aug 2023 //
BUSINESSWIRE
Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
06 Jul 2023 //
BUSINESSWIRE
